CALL FOR ABSTRACTS
Deadline — June 26, 2010
1. Participants are encouraged to submit abstracts that describe their original results.
2. The abstract must fit on a single 8½” x 11” page, one-side only. Please do not draw lines.
3. The abstract must conform to the following format: Objective; Methods; Results; and Conclusion.
4. Single space all typing, capitalize all letters in the title, underlining the name of the person presenting the paper.
5. Please email abstract as ONE file, with the file named your last name followed by first name initial. If submitting more than one abstract, please put a number at the end of the file name.
6. Please email all abstracts to email@example.com. If you do not have email, please send three copies typed on good quality bond suitable for reproduction exactly as submitted to: Maggie Fogel, 34 West 83rd Street, Suite R, New York, New York 10024, 212-873-2955, facsimile 212-873-2344.
7. Participants whose abstracts are accepted will be assigned to present their work in the scheduled Poster Session.
8. Please include on a separate page the presenter’s name, address, telephone and fax numbers, email address, title of abstract, and please restate the objectives in the format:
“From viewing and discussing my poster the participants should be able to: a. Describe . . . b. Reply . . . c. Evaluate . . .” Objectives must start with an action verb so that the activity could be measurable.
9. There are three categories of awards for your abstract submission. The winner of each category will receive a check for $500. Please indicate on your cover page which award you are eligible for:
The Young Investigator Award. Applicants must be 35 years old or younger.
Dr. Peter Maxim Memorial Laboratory Manager Award. Applicants are to be a Laboratory Manager.
Doctorate Award. Applicants are to be a Ph.D. or M.D.
10. Please indicate on your cover page whether you would like to be considered for one of a limited number of $1000 Travel Allowance Scholarships.
REMOVAL OF CIRCULATING IMMUNE COMPLEXES OF ERYTHROCYTE TRANSFUSION IN PATIENTS WITH AIDS AND ARC
Y. Inada, J. Sulzberger, and W. S. Clark, St. Luke’s Roosevelt Hosp., Columbia Univ., New York, NY USA
Objective: We have demonstrated that the absence of . . .
Methods: Ten of 18 AIDS patients . . .
Results: All control AIDS patients . . .
Conclusion: Our observations to date suggest . . .